文献速递牙周病

牙周手术辅助全身抗菌药治疗牙龈卟啉单胞菌阳性患者的48个月随机临床试验

Efficacy of Periodontal Surgery With Adjunctive Systemic Antimicrobials in Patients Harbouring Porphyromonas gingivalis: A 48-Month Randomised Clinical Trial.
PubMed 文献 · J Clin Periodontol · 2025-11-18

本研究比较牙周手术辅助全身阿奇霉素或甲硝唑在牙龈卟啉单胞菌阳性的III/IV期牙周炎患者中的临床和微生物学结局。两组临床结局均改善并保持稳定,PD减少无显著差异;48个月时AZI组80%、MET组70.6%仍检出P. gingivalis,两种方案均未将其抑制至检测限以下。

要点

  • 牙周手术辅助阿奇霉素或甲硝唑在48个月内临床结局均改善且稳定。
  • 两组在12和48个月时PD减少无统计学显著差异。
  • 48个月时P. gingivalis检出率AZI组80%、MET组70.6%,均未根除。

核心结论

  • 牙周手术辅助全身阿奇霉素或甲硝唑后临床结局改善并长期稳定,但均未能将牙龈卟啉单胞菌抑制至检测限以下。

研究设计与样本

  • 随机临床试验,纳入牙龈卟啉单胞菌阳性、牙周基础治疗后6周再评估时探诊深度≥6 mm且超过两个牙/象限的III和IV期牙周炎患者。
  • 12个月和48个月随访完成人数分别为40和36。

主要发现

  • 两组临床结局均改善并随时间保持稳定。
  • 12和48个月时两组间PD减少无统计学显著差异。
  • 48个月时牙龈卟啉单胞菌检出率阿奇霉素组为80%,甲硝唑组为70.6%。
  • 最终访视时,牙龈卟啉单胞菌阳性与阴性患者之间临床终点无差异。

临床怎么用

  • 对于牙龈卟啉单胞菌阳性的III/IV期牙周炎患者,牙周手术辅助全身阿奇霉素或甲硝唑均可改善临床结局并长期稳定。
  • 不应期望上述抗菌方案能根除牙龈卟啉单胞菌。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To compare the clinical and microbiological outcomes after the use of systemic antimicrobials as adjuncts to periodontal surgery in patients with periodontitis stage III and IV positive for Porphyromonas gingivalis. MATERIAL AND METHODS: Patients positive for P. gingivalis at the re-evaluation 6 weeks after subgingival instrumentation and with probing depths (PD) ≥ 6 mm in more than two teeth per quadrant were randomly allocated to periodontal surgery with adjunctive systemic azithromycin (AZI) or metronidazole (MET). Clinical and microbiological outcomes were evaluated at 6, 12 and 48 months after surgery. RESULTS: Forty-three subjects were included, with 40 and 36 completing follow-ups at 12 and 48 months, respectively. Clinical outcomes improved and remained stable over time in both groups. No statistically significant differences were observed between groups for PD reductions at 12 or 48 months. At 48 months, P. gingivalis was detected in 80% (AZI) and 70.6% (MET). At the final visit, no differences in clinical endpoints were observed between patients harbouring P. gingivalis and those who were not. CONCLUSIONS: Slight differences were observed between the groups, with clinical outcomes improving and remaining stable over time following surgical treatment. Neither protocol suppressed P. gingivalis beyond detection limit 48 months after treatment.

来源:J Clin Periodontol,查看原文。版权归原作者所有。

引用

  1. Albornoz AC, Montero E, Pickert FN, et al. Efficacy of Periodontal Surgery With Adjunctive Systemic Antimicrobials in Patients Harbouring Porphyromonas gingivalis: A 48-Month Randomised Clinical Trial. J Clin Periodontol. 2025. PMID: 41253131. doi:10.1111/jcpe.70060

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。